Field Sales Representative Dermatology
About the job
- A successfully completed university degree in a natural-science discipline, pharmaceutical sales representative training, or the required expertise under Section 75 of the German Medicines Act.
- Successful field sales experience in the pharmaceutical industry is advantageous but not required.
- Ability to explain complex scientific topics to different target groups and discuss them with varied customer groups.
- Strong persuasive and closing abilities and well-developed communication skills.
- Agility and motivation to pursue and achieve goals.
- Strong digital competence and analytical skills, combined with creativity.
- A pioneering mindset and strong will to succeed, including motivation for personal development within the company.
- Flexibility, commitment, and ability to work as part of a team.
- Very good spoken and written English.
- Candidates may be entry-level professionals; enthusiasm, empathy, and interest in sales are important.
- Provide professional information, present, and market relevant AbbVie products to community-based specialists and hospital specialists, in accordance with Section 75 of the German Medicines Act and pharmaceutical representative obligations.
- Present and market products to target groups according to the established brand strategy, using an omnichannel approach and the relevant marketing mix.
- Design, organize, and conduct training events, and attend regional and national events.
- Continuously analyze available market data on own-product and competitor sales performance, identify opportunities and critical developments, and derive strategic activities for targeting and account plans.
- Design, coordinate, and implement a territory plan within the in-field team.
- Collect market information and customer insights and determine customers’ positions in the sales cycle.
- Maintain regular communication with the regional manager, colleagues, and cross-functional teams, and promote ongoing exchange of experience and ideas.
- Proactively and continuously address customer needs.
- Share responsibility for achieving regional goals.
- Complete all administrative tasks and reporting accurately and on time.
- Comply with applicable functional requirements and legal and regulatory obligations, including ethics and compliance procedures and the Code of Business Conduct.
- Pharmaceutical-industry field sales experience.
About the company
AbbVie is a global biopharmaceutical company that develops and sells medicines to treat serious health conditions. Its portfolio spans immunology, oncology, virology, neuroscience, and aesthetics, with products designed to modulate the immune system, target disease pathways, or support medical aesthetics. AbbVie compounds its products through a heavy emphasis on research and development, investing billions to build a steady pipeline of new therapies. Its medicines are brought to market by selling to healthcare providers, hospitals, and clinics, and in some cases directly to patients via prescriptions. The company differentiates itself through a wide, globally distributed product line, substantial R&D investment, and a commitment to sustainability and patient care, including science-based targets. AbbVie’s goal is to improve patient outcomes by delivering effective treatments for unmet medical needs while pursuing long-term, responsible growth across healthcare markets.
Company Size
10,001+
Company Stage
IPO
Headquarters
North Chicago, Illinois
Founded
1888
Get referred to AbbVie
See people who can refer or advise you
Simplify's Take
What believers are saying
- Apogee acquisition closed in 2026, expanding AbbVie’s immunology pipeline beyond Skyrizi and Rinvoq.
- EU approvals for RINVOQ and EPKINLY in September 2026 broaden ex-U.S. revenue.
- JUVMO launches in October 2026, adding a fresh neuroscience revenue line.
What critics are saying
- Humira, Skyrizi, and Rinvoq concentration keeps AbbVie exposed if immunology growth slows in 2027.
- Niaspan antitrust MDL and Biocell ALCL settlements carried $1.7 billion litigation accrual by June 2026.
- Generic ubrogepant and atogepant suits threaten Ubrelvy and Qulipta exclusivity within years.
What makes AbbVie unique
- Skyrizi and Rinvoq anchor AbbVie’s post-Humira immunology franchise across 11 EU RINVOQ indications.
- JUVMO’s September 28, 2026 FDA approval gives AbbVie first-in-class Parkinson’s D1/D5 therapy.
- AbbVie pairs blockbuster cash flows with Apogee, Iambic, and Valkai deal-making.
Help us improve and share your feedback! Did you find this helpful?
Benefits
- Remote Work Options
- Flexible Work Hours
- Professional Development Budget